Last reviewed · How we verify
NCT05443893
Artificial Intelligence in Kinematics Analysis
trial testing Application Research of key points detection technology in Gait in 30 participants. Status unknown.
29 July 2022
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 10 July 2022 |
| Primary completion | 29 July 2022 |
| Estimated completion | 30 August 2022 |
Drugs / interventions tested
- Application Research of key points detection technology
Conditions studied
- Gait — all drugs for Gait →
Sponsor
Peking University Third Hospital
Who can join
Adults 18 to 75, any sex, with Gait. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. Establish data sets. The private data set includes relevant parameters including video of the subject's gait and standard methods for kinematic analysis; 2. Develop new models. Based on public and private data sets, the kinematic analysis model of human key point detection is further developed. 3. Test the new model. By comparing the parameters with the standard method, the accuracy of the model was verified, and the kinematics analysis model of artificial intelligence with accuracy above 98% was obtained
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05443893
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gait
Currently open trials in the same condition.
- NCT07174973 — Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis · NA · recruiting
- NCT07085416 — Sensor Ankle Brace for Special Operations Rehabilitation · NA · recruiting
- NCT07155577 — Effects of Pes Planus on Gait at Different Inclines · recruiting
- NCT07167472 — Effects of Heel Height on Gait Parameters · recruiting
- NCT07152262 — Effects of Menstrual Cycle Phases on Gait, Pelvis, and Sleep · recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05443893 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 5 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05443893.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing